Showing results (241-250 of 249) with videos related to
Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 249 results.
Cancer Immunology, Immunotherapy : CII|November 28, 2015
Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevanceFrancisco Javier Carretero, Ana Belen Del Campo, Jose Francisco Flores-Martín, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 3, 2021
Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patientsJuan Francisco Gutiérrez-Bautista, Antonio Rodriguez-Nicolas, Antonio Rosales-Castillo, et al.Molecular & Cellular Proteomics : MCP|June 3, 2019
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.Molecular & Cellular Proteomics : MCP|August 4, 2018
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.Cancer Research|April 18, 2013
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumorsSylvie Rusakiewicz, Michaela Semeraro, Matthieu Sarabi, et al.Journal for Immunotherapy of Cancer|October 20, 2024
Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancerMarta Molina-Alejandre, Francisco Perea, Virginia Calvo, et al.Nature|December 21, 2018
Actively personalized vaccination trial for newly diagnosed glioblastomaNorbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, et al.Nature|February 9, 2019
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastomaNorbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, et al.Journal of Translational Medicine|December 16, 2011
Defining the critical hurdles in cancer immunotherapyBernard A Fox, Dolores J Schendel, Lisa H Butterfield, et al.Pageof 25